1. Home
  2. SRDX vs EFR Comparison

SRDX vs EFR Comparison

Compare SRDX & EFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • EFR
  • Stock Information
  • Founded
  • SRDX 1979
  • EFR 2003
  • Country
  • SRDX United States
  • EFR United States
  • Employees
  • SRDX N/A
  • EFR N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • EFR Trusts Except Educational Religious and Charitable
  • Sector
  • SRDX Health Care
  • EFR Finance
  • Exchange
  • SRDX Nasdaq
  • EFR Nasdaq
  • Market Cap
  • SRDX 402.2M
  • EFR 342.8M
  • IPO Year
  • SRDX 1998
  • EFR N/A
  • Fundamental
  • Price
  • SRDX $27.75
  • EFR $11.27
  • Analyst Decision
  • SRDX Buy
  • EFR
  • Analyst Count
  • SRDX 3
  • EFR 0
  • Target Price
  • SRDX $43.00
  • EFR N/A
  • AVG Volume (30 Days)
  • SRDX 113.5K
  • EFR 88.6K
  • Earning Date
  • SRDX 11-05-2025
  • EFR 01-01-0001
  • Dividend Yield
  • SRDX N/A
  • EFR 9.43%
  • EPS Growth
  • SRDX N/A
  • EFR N/A
  • EPS
  • SRDX N/A
  • EFR 1.69
  • Revenue
  • SRDX $120,801,000.00
  • EFR N/A
  • Revenue This Year
  • SRDX N/A
  • EFR N/A
  • Revenue Next Year
  • SRDX $3.38
  • EFR N/A
  • P/E Ratio
  • SRDX N/A
  • EFR $7.74
  • Revenue Growth
  • SRDX N/A
  • EFR N/A
  • 52 Week Low
  • SRDX $26.00
  • EFR $10.95
  • 52 Week High
  • SRDX $40.39
  • EFR $13.29
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 29.09
  • EFR 40.18
  • Support Level
  • SRDX $26.82
  • EFR $11.10
  • Resistance Level
  • SRDX $28.69
  • EFR $11.49
  • Average True Range (ATR)
  • SRDX 0.60
  • EFR 0.11
  • MACD
  • SRDX 0.11
  • EFR -0.00
  • Stochastic Oscillator
  • SRDX 37.82
  • EFR 37.53

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.

Share on Social Networks: